{"id":"placebo-add-on","safety":{"commonSideEffects":[{"rate":null,"effect":"Nocebo effect (negative expectation-driven symptoms)"},{"rate":null,"effect":"No pharmacologically-mediated adverse events"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo is a pharmacologically inactive substance administered alongside active medications or as a standalone intervention. Any therapeutic benefit derives from the placebo effect—a psychobiological response involving patient expectation, conditioning, and the therapeutic context rather than direct drug action. Placebo add-on formulations are typically used in research protocols or clinical practice to enhance perceived efficacy through psychological mechanisms.","oneSentence":"Placebo add-on has no active pharmacological mechanism; it is an inert substance used as a control or adjunctive treatment in clinical settings.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:36:05.670Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Adjunctive use in clinical trials or therapeutic contexts where placebo effect is therapeutically relevant"}]},"trialDetails":[{"nctId":"NCT06787079","phase":"NA","title":"Effect of Kinesio Taping Application in Addition to Pilates Exercises on Core Muscle Thickness, Cognition and Mental Fatigue in Individuals With Non-specific Low Back Pain","status":"COMPLETED","sponsor":"Istanbul Saglik Bilimleri University","startDate":"2025-05-01","conditions":"Low Back Pain, Non Specific Low Back Pain","enrollment":54},{"nctId":"NCT07482501","phase":"NA","title":"Repetitive Transcranial Magnetic Stimulation in Cardiac Autonomic Dysfunction","status":"RECRUITING","sponsor":"Afyonkarahisar Health Sciences University","startDate":"2026-03-26","conditions":"Stroke, Autonomic Dysfunction, Hemiparesis","enrollment":44},{"nctId":"NCT04223791","phase":"PHASE3","title":"Switch to Doravirine/Islatravir (DOR/ISL) in Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) (MK-8591A-018)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2020-02-18","conditions":"HIV Infection","enrollment":643},{"nctId":"NCT06948097","phase":"PHASE1","title":"Syk Inhibition in MItigating Lung Allograft Rejection (SIMILAR): A Trial to Evaluate the Safety and Tolerability of Fostamatinib in Lung Transplant Patients With Donor-Specific Antibodies","status":"NOT_YET_RECRUITING","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2026-04-01","conditions":"Lung Transplantation","enrollment":30},{"nctId":"NCT07495943","phase":"NA","title":"Effects of 2-Aticyto Complex and D-Ribose on Pain and Clinical Course in Patients With Fibromyalgia","status":"NOT_YET_RECRUITING","sponsor":"Haydarpasa Numune Training and Research Hospital","startDate":"2026-05-04","conditions":"Fibromyalgia Syndrome, Fibromyalgia","enrollment":200},{"nctId":"NCT05564390","phase":"PHASE2","title":"MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-06-18","conditions":"Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm, Acute Myeloid Leukemia Post Cytotoxic Therapy","enrollment":2000},{"nctId":"NCT04628026","phase":"PHASE3","title":"Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2","status":"RECRUITING","sponsor":"University of Ulm","startDate":"2022-09-13","conditions":"Acute Myeloid Leukemia","enrollment":650},{"nctId":"NCT06980428","phase":"PHASE1","title":"A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With Dyslipidemia","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-05-27","conditions":"Healthy Participants, Dyslipidemia","enrollment":136},{"nctId":"NCT04172532","phase":"PHASE1, PHASE2","title":"Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-01-11","conditions":"Locally Advanced Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8","enrollment":92},{"nctId":"NCT01386385","phase":"PHASE1, PHASE2","title":"Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2011-06-20","conditions":"Lung Adenocarcinoma, Lung Adenocarcinoma, Mixed Subtype, Lung Large Cell Carcinoma","enrollment":53},{"nctId":"NCT03914612","phase":"PHASE3","title":"Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-08-22","conditions":"Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma, Endometrial Endometrioid Adenocarcinoma","enrollment":813},{"nctId":"NCT07201129","phase":"PHASE3","title":"A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment","status":"RECRUITING","sponsor":"Viatris Innovation GmbH","startDate":"2026-02-09","conditions":"Nephritis, Lupus, Lupus Erythematosus, Systemic","enrollment":300},{"nctId":"NCT07492771","phase":"PHASE1","title":"MP101 in Adults With Acute Pseudomonas Aeruginosa Pneumonia","status":"NOT_YET_RECRUITING","sponsor":"MicrobiotiX Co., Ltd","startDate":"2026-03","conditions":"Pneumonia - Bacterial, Pseudomonas Aeruginosa Infection","enrollment":18},{"nctId":"NCT06247345","phase":"PHASE1","title":"A Phase Ia/Ib, First-in-human (FIH) Study for Safety, Tolerability, Pharmacokinetics (PK), and Clinical Activity Evaluation of ADEL-Y01","status":"SUSPENDED","sponsor":"Alzheimer's Disease Expert Lab (ADEL), Inc.","startDate":"2024-02-06","conditions":"Alzheimer Disease","enrollment":73},{"nctId":"NCT07094542","phase":"PHASE2","title":"Jaw Muscle Pain Post Wisdom Molar Surgery","status":"NOT_YET_RECRUITING","sponsor":"Rutgers, The State University of New Jersey","startDate":"2026-05","conditions":"Post Operative Pain, Impacted Third Molar Tooth, Muscle Pain","enrollment":80},{"nctId":"NCT02763033","phase":"PHASE2","title":"Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients","status":"COMPLETED","sponsor":"University of Michigan Rogel Cancer Center","startDate":"2017-04-26","conditions":"Hematopoietic Stem Cell Transplantation","enrollment":107},{"nctId":"NCT07123155","phase":"PHASE2","title":"Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)","status":"RECRUITING","sponsor":"Shionogi","startDate":"2025-10-30","conditions":"Pompe Disease","enrollment":45},{"nctId":"NCT07218445","phase":"PHASE4","title":"The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women With Obesity","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2026-04","conditions":"Obesity, Menopause Hot Flashes","enrollment":40},{"nctId":"NCT07479966","phase":"","title":"Resting-state Connectivity and Individual Differences in Affective Placebo Responsiveness","status":"ENROLLING_BY_INVITATION","sponsor":"Stefanie Brassen","startDate":"2022-03-27","conditions":"Condition: Healthy","enrollment":50},{"nctId":"NCT04534556","phase":"NA","title":"Wireless Nerve Stimulation Device To Enhance Recovery After Stroke","status":"RECRUITING","sponsor":"Baylor Research Institute","startDate":"2021-09-01","conditions":"Stroke, Chronic Stroke, Upper Extremity Paresis","enrollment":42},{"nctId":"NCT07276282","phase":"PHASE3","title":"Effects of Ziltivekimab on Coronary Atherosclerotic Burden in Patients With Acute Myocardial Infarction","status":"RECRUITING","sponsor":"ECRI bv","startDate":"2025-12-19","conditions":"Coronary Artery Disease, Acute Myocardial Infarction (AMI), Coronary Atherosclerosis of Native Coronary Artery","enrollment":332},{"nctId":"NCT07393360","phase":"NA","title":"Effect of a Food for Special Medical Purposes on Muscle Mass Preservation During GLP-1 RAs Weight Loss Treatment","status":"RECRUITING","sponsor":"Pharmanutra S.p.a.","startDate":"2025-12-11","conditions":"Obesity & Overweight","enrollment":144},{"nctId":"NCT05467657","phase":"NA","title":"Transcranial Magnetic Stimulation on Somtosensory Cortex Enhances Motor Learning in People With Stroke","status":"COMPLETED","sponsor":"Neuron, Spain","startDate":"2023-11-15","conditions":"Transcranial Magnetic Stimulation, Stroke, Motor Learning","enrollment":20},{"nctId":"NCT04877691","phase":"PHASE3","title":"Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2021-06-08","conditions":"Systemic Lupus Erythematosus","enrollment":367},{"nctId":"NCT07482046","phase":"PHASE2, PHASE3","title":"Effectiveness of Topical Menthol as A Cooling Method During Exercise in A Recreational Runner Population","status":"COMPLETED","sponsor":"Taisho Pharmaceutical Indonesia","startDate":"2023-05-30","conditions":"Heat Stress, Athletic Performance","enrollment":37},{"nctId":"NCT07227948","phase":"PHASE2","title":"Repurposing Semaglutide for the Treatment of Cocaine Use Disorder","status":"RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2026-01-15","conditions":"Cocaine Use Disorder","enrollment":75},{"nctId":"NCT06750289","phase":"PHASE3","title":"Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-03-28","conditions":"Eosinophilic Asthma","enrollment":400},{"nctId":"NCT06455449","phase":"PHASE3","title":"A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2024-06-20","conditions":"Polymyositis, Dermatomyositis","enrollment":240},{"nctId":"NCT01577082","phase":"PHASE3","title":"Efficacy and Safety of CHF 1535 200/6µg in Not Adequately Controlled Asthmatic Patients","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2012-04-20","conditions":"Asthma","enrollment":542},{"nctId":"NCT05126277","phase":"PHASE3","title":"Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2022-07-14","conditions":"Lupus Nephritis","enrollment":462},{"nctId":"NCT07481032","phase":"NA","title":"Effect of Fufang Biejiaruangan Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis: A Multicenter, Randomized, Placebo-controlled Study","status":"NOT_YET_RECRUITING","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2026-04-01","conditions":"Cirrhosis, Liver, Hepatocellular Carcinoma (HCC), HEPATITIS B CHRONIC","enrollment":1034},{"nctId":"NCT06896669","phase":"NA","title":"Effects of Vitamin D and Calcium on Hyperglycemia and Dyslipidemia in Patients Gestational Diabetes","status":"COMPLETED","sponsor":"Riphah International University","startDate":"2025-01-28","conditions":"Diabetes Mellitus, Gestational","enrollment":60},{"nctId":"NCT05842330","phase":"PHASE3","title":"Benefits of ADHD Treatment in Detained People","status":"RECRUITING","sponsor":"Stéphanie Baggio","startDate":"2024-01-01","conditions":"ADHD","enrollment":150},{"nctId":"NCT03100149","phase":"PHASE2","title":"A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2017-06-27","conditions":"Parkinson's Disease","enrollment":316},{"nctId":"NCT05487885","phase":"PHASE4","title":"Anhedonia, Development, and Emotions: Phenotyping and Therapeutics","status":"COMPLETED","sponsor":"Erika Forbes","startDate":"2022-07-22","conditions":"Depression, Anhedonia","enrollment":123},{"nctId":"NCT07473570","phase":"PHASE1","title":"A Study（Phase I）of GS3-007a Dry Suspension in Healthy Chinese Adults","status":"RECRUITING","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2026-01-07","conditions":"Healthy Adults","enrollment":32},{"nctId":"NCT06582888","phase":"EARLY_PHASE1","title":"Advancing VR-based Attentional Bias as a Biomarker for Tobacco Use Disorder","status":"RECRUITING","sponsor":"University of California, San Diego","startDate":"2024-11-19","conditions":"Nicotine Addiction, Craving","enrollment":200},{"nctId":"NCT07475065","phase":"PHASE2, PHASE3","title":"The Effect of Oral DLBS1033 in Patients With Diabetic Polyneuropathy","status":"NOT_YET_RECRUITING","sponsor":"Universitas Sebelas Maret","startDate":"2026-03-01","conditions":"Diabetic Polyneuropathy, Peripheral Nervous System Diseases, Peripheral Neuropathy","enrollment":34},{"nctId":"NCT05811351","phase":"PHASE2","title":"A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2023-03-06","conditions":"Geographic Atrophy","enrollment":305},{"nctId":"NCT07471178","phase":"PHASE4","title":"Mycological Efficacy and Safety of Ketoconazole 2% Shampoo With a Seven-Day Versus Three-Day Treatment Duration in Pityriasis Versicolor","status":"NOT_YET_RECRUITING","sponsor":"Fakultas Kedokteran Universitas Indonesia","startDate":"2026-02","conditions":"Pityriasis Versicolor","enrollment":76},{"nctId":"NCT04175600","phase":"PHASE3","title":"A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension","status":"ACTIVE_NOT_RECRUITING","sponsor":"Actelion","startDate":"2020-01-16","conditions":"Hypertension, Pulmonary","enrollment":138},{"nctId":"NCT04118387","phase":"PHASE4","title":"Central Sleep Apnea : Physiologic Mechanisms to Inform Treatment","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2021-01-07","conditions":"Sleep Disordered Breathing, Able Bodied","enrollment":200},{"nctId":"NCT07227454","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder","status":"RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2026-01-08","conditions":"Depressive Disorder, Major","enrollment":258},{"nctId":"NCT07471867","phase":"PHASE4","title":"Effect of ZaStaprazan on Platelet Reactivity of Clopidogrel After PercuTaneous CoronAry InteRvention","status":"NOT_YET_RECRUITING","sponsor":"Yonsei University","startDate":"2026-03-17","conditions":"Chronic Coronary Syndrome","enrollment":100},{"nctId":"NCT06365892","phase":"NA","title":"Open-label Placebo (COLP) for Pain in Adolescent Idiopathic Scoliosis (AIS) Surgery+Surgical Treatment of Idiopathic Scoliosis","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2024-07-01","conditions":"Adolescent Idiopathic Scoliosis (AIS)","enrollment":64},{"nctId":"NCT04105114","phase":"EARLY_PHASE1","title":"Transformation of Paralysis to Stepping","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Louisville","startDate":"2019-09-30","conditions":"Spinal Cord Injuries","enrollment":15},{"nctId":"NCT04769206","phase":"PHASE1, PHASE2","title":"Enhancing Parasympathetic Activity to Improve Endothelial Dysfunction, Vascular Oxidative Stress in African Americans","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2021-12-20","conditions":"Endothelial Dysfunction","enrollment":46},{"nctId":"NCT07006636","phase":"NA","title":"Effect of Watermelon on Cardiometabolic Health","status":"NOT_YET_RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2026-04-01","conditions":"Cardiometabolic Health Indicators, Whole-body Antioxidant Capacity","enrollment":22},{"nctId":"NCT06353529","phase":"PHASE4","title":"Postop Pain Management in Pituitary Tumour Patients","status":"RECRUITING","sponsor":"Hamilton Health Sciences Corporation","startDate":"2024-11-25","conditions":"Pituitary, Pain, Postoperative","enrollment":108},{"nctId":"NCT07452744","phase":"NA","title":"Efficacy and Safety of Picroliv in Patients With Non-Alcoholic Fatty Liver Disease","status":"ENROLLING_BY_INVITATION","sponsor":"Bioagile Therapeutics Pvt. Ltd.","startDate":"2024-08-13","conditions":"Non Alcholic Fatty Liver Disease","enrollment":170},{"nctId":"NCT05275686","phase":"PHASE2","title":"Effect of Novel Exhalational Delivery System With Fluticasone (EDS-FLU) on Eustachian Tube Dysfunction (ETD)","status":"RECRUITING","sponsor":"Cedars-Sinai Medical Center","startDate":"2022-04-20","conditions":"Eustachian Tube Dysfunction","enrollment":80},{"nctId":"NCT05649137","phase":"PHASE3","title":"A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2023-01-04","conditions":"Obesity, Diabetes Mellitus, Type 2","enrollment":512},{"nctId":"NCT06655025","phase":"NA","title":"The Effects of Dexmedetomidine on Postoperative Cognitive Function in Open Heart Surgery","status":"COMPLETED","sponsor":"Sohag University","startDate":"2023-10-08","conditions":"Cardiac Surgery, Postoperative Cognitive Dysfunction, Neurologic Manifestations","enrollment":32},{"nctId":"NCT05636176","phase":"PHASE3","title":"A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation","status":"RECRUITING","sponsor":"Novo Nordisk A/S","startDate":"2023-05-08","conditions":"Heart Failure","enrollment":5600},{"nctId":"NCT06200207","phase":"PHASE3","title":"A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation","status":"RECRUITING","sponsor":"Novo Nordisk A/S","startDate":"2024-04-01","conditions":"Heart Failure, Systemic Inflammation","enrollment":680},{"nctId":"NCT03811561","phase":"PHASE3","title":"A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novo Nordisk A/S","startDate":"2019-05-08","conditions":"Diabetes Mellitus, Type 2","enrollment":1500},{"nctId":"NCT03833167","phase":"PHASE3","title":"Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2019-04-01","conditions":"Carcinoma, Squamous Cell","enrollment":450},{"nctId":"NCT07399860","phase":"PHASE2","title":"Botulinum Toxin A Before Hemorrhoidectomy to Prevent Postoperative Pain","status":"RECRUITING","sponsor":"Lomonosov Moscow State University Medical Research and Educational Center","startDate":"2026-02-01","conditions":"Hemorrhoids, Postoperative Pain","enrollment":292},{"nctId":"NCT07459231","phase":"NA","title":"The Effect of Kinesio Taping During Labor on Low Back Pain, Vaginal Birth Self-Efficacy, Postpartum Comfort Perception, and Newborn Apgar Scores","status":"COMPLETED","sponsor":"Ege University","startDate":"2025-07-20","conditions":"Low Back Pain, Pregnancy, Midwifery","enrollment":75},{"nctId":"NCT06290934","phase":"PHASE2","title":"Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Gilead Sciences","startDate":"2024-03-27","conditions":"Ulcerative Colitis","enrollment":228},{"nctId":"NCT07459699","phase":"NA","title":"Effects of Probiotics on the Gut-brain Axis in Children","status":"NOT_YET_RECRUITING","sponsor":"Probi AB","startDate":"2026-03","conditions":"Attention Deficit Hyperactivity Disorder (ADHD)","enrollment":80},{"nctId":"NCT04520139","phase":"PHASE1, PHASE2","title":"Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT","status":"NOT_YET_RECRUITING","sponsor":"University of California, Irvine","startDate":"2026-03","conditions":"Ovarian Cancer, Cognitive Impairment","enrollment":102},{"nctId":"NCT05138757","phase":"PHASE1, PHASE2","title":"Pinpoint Trial: Prebiotics IN Peanut Oral ImmunoTherapy","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2021-11-30","conditions":"Peanut Allergy","enrollment":20},{"nctId":"NCT06834932","phase":"PHASE2, PHASE3","title":"A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of AZD0780 in Participants With Dyslipidaemia","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2024-12-06","conditions":"Dyslipidaemia","enrollment":360},{"nctId":"NCT03221426","phase":"PHASE3","title":"Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2017-10-09","conditions":"Gastric Cancer, Gastroesophageal Junction Cancer","enrollment":1007},{"nctId":"NCT05360446","phase":"PHASE3","title":"Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2022-07-08","conditions":"Coronary Artery Disease","enrollment":610},{"nctId":"NCT05371496","phase":"PHASE2","title":"Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction","status":"ENROLLING_BY_INVITATION","sponsor":"Mayo Clinic","startDate":"2022-09-06","conditions":"Cardiomyopathy, Heart Failure With Preserved Ejection Fraction (HFpEF), Obesity","enrollment":81},{"nctId":"NCT07456176","phase":"PHASE3","title":"Effect of Low-Dose Versus High-Dose Alpha-Lipoic Acid on Oxidative Stress, Inflammation, and Clinical Outcomes in Acute Exacerbations of Chronic Obstructive Pulmonary Disease","status":"NOT_YET_RECRUITING","sponsor":"Ain Shams University","startDate":"2026-02-28","conditions":"Acute Exacerbation Chronic Obstructive Pulmonary Disease","enrollment":75},{"nctId":"NCT07432399","phase":"PHASE2","title":"Effect of Perioperative Lidocaine or High-Dose Dexamethasone on Immune Response in Colon Cancer Surgery (PILDI Study)","status":"RECRUITING","sponsor":"Institute of Oncology Ljubljana","startDate":"2025-09-01","conditions":"Colon Cancer, Colorectal Cancer, Perioperative Immune Response","enrollment":100},{"nctId":"NCT04456816","phase":"PHASE2","title":"A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Treatment With AP1189 in Patients With iMN and Severe Proteinuria","status":"RECRUITING","sponsor":"SynAct Pharma Aps","startDate":"2020-08-31","conditions":"Nephrotic Syndrome Due to Idiopathic Membranous Nephropathy, Severe Proteinuria Due to Idiopathic Membranous Nephropathy","enrollment":23},{"nctId":"NCT07440979","phase":"NA","title":"Personalized Nutrition Coaching for a Weight Loss Program Among Overweight and Obese Nurses","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fakultas Kedokteran Universitas Padjadjaran","startDate":"2026-01-19","conditions":"Obesity & Overweight, Healthcare Worker, Low Physical Activity Level","enrollment":44},{"nctId":"NCT07450638","phase":"NA","title":"Effect of Preoperative Long-Acting Corticosteroids on Pain, Swelling, and Trismus After Impacted Lower Third Molar Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"Al Salam University","startDate":"2026-01-04","conditions":"Impacted Mandibular Third Molar, Postoperative Pain, Trismus","enrollment":60},{"nctId":"NCT06977932","phase":"NA","title":"The Alternative Effects of Electroacupuncture in the Treatment of Trigeminal Neuralgia","status":"NOT_YET_RECRUITING","sponsor":"Yuanyuan Wu","startDate":"2026-03-01","conditions":"Trigeminal Neuralgia","enrollment":126},{"nctId":"NCT07083154","phase":"PHASE3","title":"GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)","status":"RECRUITING","sponsor":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","startDate":"2025-09-27","conditions":"Dementia, Mild, Mild Cognitive Impairment, Type 2 Diabetes","enrollment":420},{"nctId":"NCT07229911","phase":"PHASE1","title":"A Study of TAK-781 in Healthy Volunteers and in Participants With Non-Cirrhotic Primary Sclerosing Cholangitis (PSC)","status":"RECRUITING","sponsor":"Takeda","startDate":"2026-01-07","conditions":"Healthy Volunteers, Primary Sclerosing Cholangitis","enrollment":134},{"nctId":"NCT04288245","phase":"NA","title":"Targeted Plasticity Therapy for Upper Limb Rehabilitation in Spinal Cord Injuries","status":"ACTIVE_NOT_RECRUITING","sponsor":"Baylor Research Institute","startDate":"2021-02-15","conditions":"Spinal Cord Injuries, Upper Extremity Paresis","enrollment":20},{"nctId":"NCT06992427","phase":"PHASE3","title":"High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer","status":"RECRUITING","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2025-06-05","conditions":"Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8, Stage II Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8","enrollment":228},{"nctId":"NCT05672576","phase":"PHASE3","title":"A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus","status":"ACTIVE_NOT_RECRUITING","sponsor":"Viatris Innovation GmbH","startDate":"2023-06-26","conditions":"Lupus Erythematosus, Systemic","enrollment":451},{"nctId":"NCT07282574","phase":"PHASE2","title":"A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS)","status":"RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2026-03-10","conditions":"Progressive Multiple Sclerosis","enrollment":360},{"nctId":"NCT05648500","phase":"PHASE3","title":"A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus","status":"RECRUITING","sponsor":"Viatris Innovation GmbH","startDate":"2022-12-13","conditions":"Lupus Erythematosus, Systemic","enrollment":420},{"nctId":"NCT07108153","phase":"PHASE2","title":"Proof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of SION-719 When Added to Trikafta","status":"RECRUITING","sponsor":"Sionna Therapeutics Inc.","startDate":"2025-11-03","conditions":"Cystic Fibrosis (CF)","enrollment":16},{"nctId":"NCT06272487","phase":"PHASE2","title":"Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3)","status":"COMPLETED","sponsor":"Alnylam Pharmaceuticals","startDate":"2024-02-29","conditions":"High Cardiovascular Risk, Hypertension","enrollment":375},{"nctId":"NCT04896008","phase":"PHASE3","title":"A Study of Sotatercept in Participants With PAH WHO FC III or FC IV at High Risk of Mortality (MK-7962-006/ZENITH)","status":"COMPLETED","sponsor":"Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA","startDate":"2021-12-01","conditions":"Pulmonary Arterial Hypertension","enrollment":173},{"nctId":"NCT04115033","phase":"NA","title":"Randomized Controlled Trial of CES for Fibromyalgia","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2020-03-02","conditions":"Fibromyalgia","enrollment":50},{"nctId":"NCT03675737","phase":"PHASE3","title":"Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2018-11-08","conditions":"Stomach Neoplasms","enrollment":1579},{"nctId":"NCT07435961","phase":"NA","title":"Magnetotherapy in Carpal Tunnel Syndrome: Randomized Controlled Study","status":"NOT_YET_RECRUITING","sponsor":"Fatih Sultan Mehmet Training and Research Hospital","startDate":"2026-02-01","conditions":"Magnetotherapy, Carpal Tunnel Syndrome (CTS), Median Nerve Compression","enrollment":60},{"nctId":"NCT07247721","phase":"NA","title":"Transcutaneous vs Percutaneous Electrical Stimulation of the Radial Nerve","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Castilla-La Mancha","startDate":"2026-01-15","conditions":"Pain Modulation, Sensorimotor Function, Nerve Stimulation","enrollment":120},{"nctId":"NCT06333041","phase":"PHASE2, PHASE3","title":"Study of Cannabidiol in Sanfilippo Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","startDate":"2026-03-15","conditions":"Sanfilippo Syndrome, Mucopolysaccharidosis III","enrollment":35},{"nctId":"NCT05832034","phase":"PHASE2, PHASE3","title":"Add-on Intravenous Immunoglobulins in Early Myositis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2021-09-13","conditions":"Inflammatory Myopathy, Idiopathic, Dermatomyositis, Antisynthetase Syndrome","enrollment":44},{"nctId":"NCT07441226","phase":"PHASE2","title":"Umbilical Cord Mesenchymal Stem Cells as Adjuvant Therapy in Group E COPD Patients","status":"RECRUITING","sponsor":"RSUP Persahabatan","startDate":"2025-08-08","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":20},{"nctId":"NCT05855746","phase":"PHASE3","title":"Colchicine Versus Placebo in Acute Myocarditis Patients","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-07-16","conditions":"Acute Myocarditis","enrollment":300},{"nctId":"NCT07432529","phase":"PHASE3","title":"Design and Rationale of the COLT Study","status":"NOT_YET_RECRUITING","sponsor":"Azienda Sanitaria Locale ASL 6, Livorno","startDate":"2026-06-01","conditions":"Venous Thrombosis Deep (Limbs), Post-thrombotic Syndrome, Venous Thromboembolism (VTE)","enrollment":940},{"nctId":"NCT07432893","phase":"NA","title":"Assessing the Effectiveness of Large Language Model (LLM)-Enabled Nurse Treatment Planning in 2 Indian Districts","status":"RECRUITING","sponsor":"Sarah Nabia","startDate":"2026-01-13","conditions":"Hypertension, Diabete Mellitus, Breathlessness","enrollment":672},{"nctId":"NCT05254990","phase":"PHASE3","title":"Reparixin add-on Therapy to Standard Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia","status":"TERMINATED","sponsor":"Dompé Farmaceutici S.p.A","startDate":"2022-04-27","conditions":"Infectious Pneumonia, Severe COVID-19","enrollment":414},{"nctId":"NCT05891496","phase":"PHASE3","title":"A Research Study Looking at the Effect of Semaglutide on the Immune System and Other Biological Processes in People With Alzheimer's Disease","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2023-06-20","conditions":"Alzheimers Disease","enrollment":23},{"nctId":"NCT05997264","phase":"PHASE2","title":"Anthrax AV7909 Boost Evaluation Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Biomedical Advanced Research and Development Authority","startDate":"2023-12-05","conditions":"Anthrax","enrollment":220},{"nctId":"NCT07360301","phase":"PHASE1","title":"Consciousness and Psilocybin Effects on Well-Being: The CoPEWell Study","status":"NOT_YET_RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2026-04","conditions":"Well-Being, Psychological, Psychedelic Experiences","enrollment":120},{"nctId":"NCT05799755","phase":"PHASE4","title":"Myositis Interstitial Lung Disease Nintedanib Trial","status":"COMPLETED","sponsor":"Rohit Aggarwal, MD","startDate":"2023-08-01","conditions":"Myositis Associated Interstitial Lund Disease (MA-ILD)","enrollment":49},{"nctId":"NCT07312851","phase":"PHASE1","title":"A Study to Investigate Andexanet Dosing and the Interaction Between Andexanet and Subsequent Enoxaparin in Healthy Participants","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2026-01-19","conditions":"Healthy Participants","enrollment":186},{"nctId":"NCT07426237","phase":"PHASE4","title":"Effect of the Addition of Adenosine on Myocardial Protection During Cardiopulmonary Bypass","status":"NOT_YET_RECRUITING","sponsor":"Hospital Nossa Senhora da Conceicao","startDate":"2026-03-30","conditions":"Myocardial Protection","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":37,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Placebo add-on","genericName":"Placebo add-on","companyName":"National Health Research Institutes, Taiwan","companyId":"national-health-research-institutes-taiwan","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Placebo add-on has no active pharmacological mechanism; it is an inert substance used as a control or adjunctive treatment in clinical settings. Used for Adjunctive use in clinical trials or therapeutic contexts where placebo effect is therapeutically relevant.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}